pharmaphorum2d
GSK shares dive on Zantac court case ruling
Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...
pharmaphorum9d
GSK et al win another round in Zantac cancer litigation
GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.
BioPharma Dive2d
GSK’s 5-in-1 meningococcal shot wins FDA approval
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
FiercePharma14d
After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication
The investors are seeking a jury trial and damages ... Boehringer Ingelheim. In key win for GSK, Delaware court will review decision to allow expert testimony in Zantac cases In 2020, after ...
Morningstar6d
Deadline Alert: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
who did not know that GSK had for decades concealed an internal study that implicated the Company’s liability to Zantac users; and (4) as a result, Defendants’ positive statements about the ...
Business Insider5d
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK
who did not know that GSK had for decades concealed an internal study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors ...
Hosted on MSN20d
Is it game over for the GSK share price?
The overhanging Zantac litigation case has dented investor confidence ... It’s a FTSE 100 pharmaceutical flop GSK has posted a string of drug trial wins lately. Its specialty medicines division saw ...
MoneyWeek4mon
GSK share price surges after $2.2bn Zantac drug settlement
GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.
Business Wire13d
Law Offices of Howard G. Smith Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action
who did not know that GSK had for decades concealed an internal study that implicated the Company’s liability to Zantac users; and (4) as a result, Defendants’ positive statements about the ...
Bloomberg on MSN9mon
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Suits
GSK has also settled some Zantac cases before they could go to trial. News of the Pfizer settlement ... The companies got a ...
Morningstar15d
Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Large Losses to Contact the Firm for Information About Their Rights
who did not know that GSK had for decades concealed an internal study that implicated the Company’s liability to Zantac users. When the true details entered the market, the lawsuit claims that ...
Business Insider8d
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
who did not know that GSK had for decades concealed an internal study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors ...